✦ LIBER ✦

Influence of Renal and Hepatic Impairment on the Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Fluticasone Furoate and Vilanterol in Combination

✍ Scribed by Allen, Ann; Davis, Angela; Hardes, Kelly; Tombs, Lee; Kempsford, Rodger

Book ID: 119218658
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 878 KB
Volume: 34
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2012.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Moderate Hepatic Impairment o

Effects of Moderate Hepatic Impairment on the Pharmacokinetic Properties and Tolerability of Umeclidinium and Vilanterol in Inhalational Umeclidinium Monotherapy and Umeclidinium/Vilanterol Combination Therapy: An Open-Label, Nonrandomized Study

✍ Mehta, Rashmi; Hardes, Kelly; Kelleher, Dennis; Preece, Andrew; Tombs, Lee; Brea 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Influence of Renal Impairment on the Pha

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

✍ Dr Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dago Mazur 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 207 KB

Steady-state pharmacokinetics, pharmacod

Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients

✍ Josephine F. Reyes; Ramon Vargas; Dinesh Kumar; Edward I. Cullen; Carlos A. Perd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The pharmacokinetics and pharmacodynamic

The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.

✍ EJ Begg; RA Robson; RR Bailey; KL Lynn; GJ Frank; SC Olson 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 999 KB

Influence of Severe Renal Impairment on

Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran

✍ Dr Ulf G. Eriksson, Susanne Johansson, Per-Ola Attman, Henrik Mulec, Lars Frison 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 159 KB

Influence of hepatic cirrhosis and end-s

Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

✍ E. Keller; G. Hoppe-Seyler; R. Mumm; P. Schollmeyer 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 582 KB